Our Board of Directors are responsible for the direction, strategy, organization and administration of the company.
Albert M. Baehny

Chairman of the Board of Directors of Lonza Group Ltd (since 2018), Member of the Board of Directors of Lonza Group Ltd (since April 2017).
In November 2019, Albert M. Baehny took on the responsibilities of CEO ad interim until his successor, Pierre-Alain Ruffieux, assumed the position on 1 November 2020.

Albert M. Baehny holds a degree in biology from the University of Fribourg (CH).

Current Activities and Functions

Public Company Boards:

  • Member of the Board of Directors of Investis Group Holding SA (since 2016)
  • Chairman of the Board of Directors of Geberit AG (since 2011)
Former Activities and Functions
  • CEO ad interim of Lonza Group Ltd (2019–2020)
  • CEO of Geberit Group (2005–2014)
  • Head of Group Division Marketing and Sales Europe for Geberit Group (2003–2004)
  • Senior Vice-President at Wacker Chemie AG (2001–2002)
  • Various Marketing, Sales, Strategic Planning and Global Management Positions with:
    • Vantico (2000–2001)
    • Ciba-Geigy / Ciba Specialty Chemicals (1994–2000)
    • Dow Chemicals Europe (1981–1993)
    • Serono-Hypolab (1979–1981)

Christoph Mäder

Independent member of the Board of Directors of Lonza Group Ltd (since April 2016)

On 12 November 2019 Christoph Mäder has been appointed Lead Independent Director by the Board.

Christoph Mäder holds a Master’s degree in law from the University of Basel (CH) and is admitted to the Swiss Bar.

Current Activities and Functions

Public Company Boards:

  • Member of the Board of Directors Baloise Holding AG (since 2019)
  • Member of the Board of EMS Chemie Holding AG (since 2018)

Further Appointments:

  • President of Economiesuisse (since 2020) 
  • Member of the Board of Directors Assivalor AG (since 2019)
  • Member of the Advisory Board of Accenture Switzerland (since 2019)
  • Partner at the law firm Becker-Gurini-Hanhart-Vogt (since 2019)
  • Member of the Council of Schweizer Jugend forscht (since 2018)
  • Member of the Advisory Board of Vereinigung Schweizerischer Unternehmen in Deutschland (since 2016)
  • Member of the Advisory Board of Loeba GmbH (since 2014)
Former Activities and Functions
  • Member of the Group Executive Committee of Syngenta (2000–2018)
  • Member of the Board Committee of economiesuisse (2008–2019)
  • Vice-Chairman of economiesuisse (2011–2017)
  • Member of the Executive Board of the Business and Industry Advisory Committee (BIAC) for the Organization for Economic Co-operation and Development (OECD) (2012–2016)
  • Member of the Board of scienceindustries (2006–2018)
  • Member of the Board of the Basel Chamber of Commerce (2002–2018)
  • Head of Legal & Public Affairs for Novartis Crop Protection AG (1999–2000)
  • Senior Corporate Counsel for Novartis International AG (1992–1998)

Werner Bauer

Independent member of the Board of Directors of Lonza Group Ltd (since April 2013).

Werner Bauer holds a diploma and PhD in chemical engineering from the University of Erlangen-Nürnberg (DE). He has received several scientific honors, among others the BioAlps Award 2011 and Honorary Senator from the Technical University of Munich (DE).

Current Activities and Functions

Public Company Boards:

  • Member of the Board of Directors of SIG Combibloc Group AG (since 2018)
  • Vice-Chairman of the Board of Directors of Givaudan SA (since 2014)

Further Appointments:

  • Member of the Board of Directors of the Urs Bühler Innovation Fund (since 2019)
  • Vice-Chairman of the Supervisory Board of Bertelsmann SE & Co. KGaA (since 2012)
  • Chairman of the Board of Trustees of the Bertelsmann Foundation (since 2003)
Former Activities and Functions
  • Member of the Supervisory Board of GEA Group AG (2011–2018)
  • Chairman of the Supervisory Board of Nestlé Deutschland AG (2007–2017)
  • Executive Vice-President of Nestlé SA, Head of Innovation, Technology, Research and Development (2007–2013)
  • Executive Vice-President of Nestlé SA, Head of Technical, Production, Environment, Research & Development (2002–2007)
  • Various managerial positions of increasing responsibility at Nestlé (1990–2002)
  • Chairman of the Board of Directors of Galderma Pharma SA (2011–2014)
  • Member of the Board of Directors of L’OREAL, France (2005–2012)
  • Member of the Board of Directors of Alcon Inc., Switzerland (2002–2010)
  • Director of the Fraunhofer Institute for Food Technology & Packaging and Professor in Bioprocess Technology at Technical University Munich (DE) (1985–1990)
  • Professor of Chemical Engineering at the Technical University of Hamburg (DE) (1980–1985)

Dorothée Deuring

Independent member of the Board of Directors of Lonza Group Ltd (since April 2020)

Non-Executive Director and Corporate Finance Adviser, who brings more than 25 years of experience in the fields of manufacturing, biotech, pharmaceuticals and banking. Ms Deuring currently serves on the board of several companies including Axpo, Bilfinger and Elementis. Her Board memberships span the energy, plant engineering, chemical and biopharmaceutical sectors. She received her Master of Science in Chemistry from Université Louis Pasteur, Strasbourg in 1994. In 1996 she received her Master in Business Administration from INSEAD, Fontainebleau (France).

Current activities and functions

Public Company Board Mandates:

  • Member of the Board of Directors, Member of the Audit Committee of Axpo Holding AG (since 2017)
  • Member of the Board of Directors, Member of the Audit and Remuneration Committees of Elementis PLC (since 2017)
  • Supervisory Board Member, Member of the Audit Committee of Bilfinger SE (since 2016)

Further Mandate:

  • Member of the Board of Directors of PIQUR Therapeutics AG (since 2019)

Activity:

  • Independent Corporate Finance Adviser (since 2014)
Former activities and functions
  • Member of the Board of Directors of Selecta AG (2020)
  • Supervisory Board Member (Beirat) of Röchling Group SE & Co. KG (2016–2019)
  • Head of Corporate Advisory Group Europe, Managing Director Wealth Management Division of UBS AG (2011–2014)
  • Managing Director Investment Banking, Head Healthcare and Chemicals M&A of Bankhaus Sal. Oppenheim Jr & Cie (2007–2009)
  • Vice Director, Corporate Finance, Mergers & Acquisitions; Vice Director, Diagnostics Division, Business Development for F. Hoffman-La Roche AG (2003–2007)
  • Founder, Owner Manager and Board Member of CoCap AG (1998–2003)
  • Consultant of McKinsey & Company (1997–1998)
  • Managing Director of K. Deuring & Co (1993–1997)
Angelica Kohlmann

Independent member of the Board of Directors of Lonza Group Ltd (since May 2018).

Angelica Kohlmann holds a MD and doctorate in medicine from Hamburg University (DE).

Current Activities and Functions
  • Member International Advisory Board IE University and Business School, Madrid(since 2017)
  • Chairman Board of Directors, Bloom Diagnostics AG (since 2014)
  • Chairman Board of Directors, Kohlmann & Co AG (since 2013)
  • International investor in biotech and tech, based in Switzerland (since 2014)
  • Board Observer Teralytics AG (since 2017)
  • Chairperson of the Advisory Board Peter Drucker Society Europe / Global Peter Drucker Forum, Vienna (since 2009)
Former Activities and Functions
  • Member Advisory Board UBS Unique (2017–2018)
  • Director Trinnacle Fund Ltd (2016–2017)
  • Member Board of Directors Teralytics AG (2013–2016)
  • Founder & CEO Ifitech GmbH, Germany (2010–2017)
  • International investor in biotech and tech, based in Germany (2000–2013)
  • International consultant for strategy, management, investments and restructuring (1992–1999)
  • Head global restructuring Behringwerke AG, Germany (1990–1992)
  • Member Board Staff Hoechst AG, Germany (1988–1990)
  • International Marketing Group Leader at Behringwerke AG (1986–1988)
  • MD Anderson Cancer Center, Houston and Memorial Sloan Kettering Cancer Center, New York, USA – various cancer research functions

Barbara Richmond

Independent member of the Board of Directors of Lonza Group Ltd (since April 2014).

Barbara Richmond holds a first-class degree in management science from the University of Manchester Institute of Science and Technology in England. Barbara Richmond has substantial knowledge as a financial expert, demonstrated by her roles as CFO for various companies. She is a Fellow of the Institute of Chartered Accountants in England and Wales.

Current Activities and Functions

Public Company Boards:

  • Group CFO of Redrow plc (since 2010)
Former Activities and Functions
  • Group CFO of Inchcape plc (2006–2009)
  • Non-Executive Director and Audit Committee Chair of Scarborough Building Society until its merger with The Skipton Building Society (2005–2009)
  • Non-Executive Director, Senior Independent Director and Audit Committee Chair of Carclo Group plc (2000–2006)
  • Group CFO of Croda International plc (1997–2006) with dual role as Group CFO and President of Active Ingredients and Industrial Chemicals from 2002 to 2006
  • Group CFO of Whessoe plc in 1993 (1993–1997)
  • Various financial roles in Alstom Group SA (1987–1992)
  • Auditor and management consultant for Arthur Andersen (1981–1984)

Jürgen Steinemann

Member of the Board of Directors of Lonza Group Ltd (since April 2014)

Jürgen Steinemann holds a degree in Economics and Business Management from the European Business School in Wiesbaden (DE), London (UK) and Paris (FR).

Current Activities and Functions

Public Company Boards: 

  • Member of the Board of Directors of Barry Callebaut AG (since 2015)
  • Chairman of the Supervisory Board of Metro AG (since 2015)

Further Appointments:

  • Investor in food and agro businesses
  • Managing Director of JBS Holding GmbH (since 2017)
  • Chairman of the Supervisory Board of Bankiva B.V. (since 2017)
  • Member of the Advisory Board of Tower Brook Capital Partners LP (since 2017)
  • Member of the Supervisory Board of Big Dutchman AG (since 2015)
Former Activities and Functions
  • Chief Executive Officer of Barry Callebaut Ltd (2009–2015)
  • Member of the Board of the Swiss-American Chamber of Commerce (2011–2015)
  • Member of the Executive Board and Chief Operating Officer of Nutreco (2001–2009)
  • Chief Executive Officer of Loders Croklaan (1999–2001)
  • Various senior positions in business-to-business marketing and sales with the former Eridania Béghin-Say Group, ultimately in the «Corporate Plan et Stratégie» unit at the head office in Paris (1990–1998)

Olivier Verscheure

Independent member of the Board of Directors of Lonza Group Ltd (since May 2018)

Olivier Verscheure holds a PhD in computer science from the Swiss Federal Institute of Technology, Lausanne (CH) (EPFL, July 1999).

Current Activities and Functions
  • Expert in the Strategy Working Group on Data, Computing and Digital Research lnfrastructures in the State Secretariat for Education, Research and Innovation (SERI) (since 2019)
  • Member of the Foundation Council of SWITCH (since 2019)
  • Founder and Executive Director of the Swiss Data Science Center, a joint venture between EPFL and ETH Zürich (since 2016)
  • Member of the Executive Committee of Personalized Health and Related Technologies (PHRT), an ETH Domain Strategic Focus Area (since 2017)
  • Co-academic Director, Certificate of Advanced Studies (CAS), Data Science and Management, HEC Lausanne and EPFL (since 2018)
Former Activities and Functions
  • Lab Program Director and Senior Research Manager at IBM Research Ireland(2010 – 2016)
  • Research Manager and Senior Member of the Research Staff at the IBM T.J. Watson Research Center (1999 – 2010)